LeadIQ logo
Learn more at LeadIQ.com

Insights

Rare Disease Therapies Eiger BioPharmaceuticals focuses on developing innovative therapies for rare metabolic diseases like post-bariatric hypoglycemia and congenital hyperinsulinism, presenting a unique sales opportunity for targeting niche patient populations.

Product Acquisition Recent asset sales to companies like Amylyx Corp and Sentynl Therapeutics indicate potential sales opportunities for partnering or acquiring Eiger's products, especially for companies seeking to expand their rare disease treatment portfolios.

Bankruptcy Challenges Eiger's Chapter 11 bankruptcy proceedings imply opportunities for strategic investors or acquirers to capitalize on the company's assets or technology at potentially favorable terms, making it a unique sales prospect in the biopharmaceutical sector.

CEO Transitions The appointments and transitions in Eiger's CEO position suggest potential sales opportunities for service providers offering executive search, leadership development, or consulting services to support the company's growth and strategic direction.

Market Positioning Eiger's focus on developing peginterferon lambda for hepatitis delta virus infection presents a sales opportunity for companies operating in the antiviral therapeutics space, enabling strategic collaborations or licensing agreements to leverage Eiger's advancements in this segment.

Similar companies to Eiger BioPharmaceuticals

Eiger BioPharmaceuticals Tech Stack

Eiger BioPharmaceuticals uses 8 technology products and services including jQuery CDN, WordPress, NetSuite, and more. Explore Eiger BioPharmaceuticals's tech stack below.

  • jQuery CDN
    Content Delivery Network
  • WordPress
    Content Management System
  • NetSuite
    E-commerce
  • WooCommerce
    E-commerce
  • Acquia Cloud Platform
    Platform As A Service
  • Yoast SEO
    Search Engines
  • Bootstrap
    UI Frameworks
  • Drupal Multisite
    Web Hosting

Media & News

Eiger BioPharmaceuticals's Email Address Formats

Eiger BioPharmaceuticals uses at least 1 format(s):
Eiger BioPharmaceuticals Email FormatsExamplePercentage
FLast@eigerbio.comJDoe@eigerbio.com
49%
LFirst@eigerbio.comDJohn@eigerbio.com
1%
Last@eigerbio.comDoe@eigerbio.com
1%
FLast@eigerbio.comJDoe@eigerbio.com
49%

Frequently Asked Questions

Where is Eiger BioPharmaceuticals's headquarters located?

Minus sign iconPlus sign icon
Eiger BioPharmaceuticals's main headquarters is located at US. The company has employees across 4 continents, including North AmericaEuropeAsia.

What is Eiger BioPharmaceuticals's phone number?

Minus sign iconPlus sign icon
You can contact Eiger BioPharmaceuticals's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Eiger BioPharmaceuticals's stock symbol?

Minus sign iconPlus sign icon
Eiger BioPharmaceuticals is a publicly traded company; the company's stock symbol is EIGRQ.

What is Eiger BioPharmaceuticals's official website and social media links?

Minus sign iconPlus sign icon
Eiger BioPharmaceuticals's official website is eigerbio.com and has social profiles on LinkedIn.

How much revenue does Eiger BioPharmaceuticals generate?

Minus sign iconPlus sign icon
As of June 2024, Eiger BioPharmaceuticals's annual revenue reached $12M.

What is Eiger BioPharmaceuticals's SIC code NAICS code?

Minus sign iconPlus sign icon
Eiger BioPharmaceuticals's SIC code is 8661 - Religious Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Eiger BioPharmaceuticals have currently?

Minus sign iconPlus sign icon
As of June 2024, Eiger BioPharmaceuticals has approximately 26 employees across 4 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: D. A.Chief Business Officer: I. C.Vice President Of Global Operations: B. N.. Explore Eiger BioPharmaceuticals's employee directory with LeadIQ.

What industry does Eiger BioPharmaceuticals belong to?

Minus sign iconPlus sign icon
Eiger BioPharmaceuticals operates in the Biotechnology Research industry.

What technology does Eiger BioPharmaceuticals use?

Minus sign iconPlus sign icon
Eiger BioPharmaceuticals's tech stack includes jQuery CDNWordPressNetSuiteWooCommerceAcquia Cloud PlatformYoast SEOBootstrapDrupal Multisite.

What is Eiger BioPharmaceuticals's email format?

Minus sign iconPlus sign icon
Eiger BioPharmaceuticals's email format typically follows the pattern of . Find more Eiger BioPharmaceuticals email formats with LeadIQ.

How much funding has Eiger BioPharmaceuticals raised to date?

Minus sign iconPlus sign icon
As of June 2024, Eiger BioPharmaceuticals has raised $5M in funding. The last funding round occurred on Jun 07, 2022 for $5M.
Eiger BioPharmaceuticals

Eiger BioPharmaceuticals

Biotechnology ResearchUnited States11-50 Employees

Eiger is a commercial-stage biopharmaceutical company focused on the development of innovative therapies for rare metabolic diseases. Eiger's lead product candidate, avexitide, is a well characterized, first-in-class GLP-1 antagonist for the treatment of post-bariatric hypoglycemia (PBH) and congenital hyperinsulinism (HI). Avexitide is the only drug in development for PBH with Breakthrough Therapy designation from the FDA.
 
For additional information about Eiger and its clinical programs, please visit www.eigerbio.com.

For our social media and community guidelines, including information on how to report adverse events, please visit www.eigerbio.com/social-media-guidelines/

Section iconCompany Overview

Headquarters
US
Phone number
SIC Code
8661 - Religious Organizations
Stock Symbol
EIGRQ
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
11-50

Section iconFunding & Financials

  • $5M

    Eiger BioPharmaceuticals has raised a total of $5M of funding over 10 rounds. Their latest funding round was raised on Jun 07, 2022 in the amount of $5M.

  • $10M$50M

    Eiger BioPharmaceuticals's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $5M

    Eiger BioPharmaceuticals has raised a total of $5M of funding over 10 rounds. Their latest funding round was raised on Jun 07, 2022 in the amount of $5M.

  • $10M$50M

    Eiger BioPharmaceuticals's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.